|  Help  |  About  |  Contact Us

Publication : Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia.

First Author  Cho JY Year  2004
Journal  Proc Natl Acad Sci U S A Volume  101
Issue  2 Pages  609-14
PubMed ID  14699054 Mgi Jnum  J:88289
Mgi Id  MGI:3032479 Doi  10.1073/pnas.2237184100
Citation  Cho JY, et al. (2004) Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia. Proc Natl Acad Sci U S A 101(2):609-14
abstractText  Mutations of fibroblast growth factor receptor 3 (FGFR3) are responsible for achondroplasia (ACH) and related dwarfing conditions in humans. The pathogenesis involves constitutive activation of FGFR3, which inhibits proliferation and differentiation of growth plate chondrocytes. Here we report that activating mutations in FGFR3 increase the stability of the receptor. Our results suggest that the mutations disrupt c-Cbl-mediated ubiquitination that serves as a targeting signal for lysosomal degradation and termination of receptor signaling. The defect allows diversion of actively signaling receptors from lysosomes to a recycling pathway where their survival is prolonged, and, as a result, their signaling capacity is increased. The lysosomal targeting defect is additive to other mechanisms proposed to explain the pathogenesis of ACH.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression